Skip to content
2000
Volume 21, Issue 10
  • ISSN: 1573-3998
  • E-ISSN: 1875-6417

Abstract

Background

Diabetic peripheral neuropathy (DPN) is the prevalent microvascular complication of diabetes mellitus (DM). 30-50% of diabetics are likely to be affected by DPN. It significantly impacts the skeletal muscles, resulting in an accelerated loss of muscle mass. The objective of this systematic review was to evaluate the ankle and foot muscle changes in diabetic peripheral neuropathy using ultrasound.

Methods

A comprehensive search was conducted in Scopus, Embase, and PubMed databases, which yielded 64 studies, out of which 5 studies are included in this meta-analysis.

Results

The meta-analysis shows that the thickness and cross-section area of the extensor digitorum brevis muscle are reduced in DPN as compared to the control group with value<0.004 and -value<0.001, respectively. The thickness of MIL muscle was also smaller in DPN -value=0.02. Similarly, the thickness and CSA of AH muscle are also reduced in DPN patients compared to the control group, with -values of 0.21 and 0.14.

Conclusion

Meta-analysis reveals that diabetic peripheral neuropathy (DPN) patients have reduced foot muscle thickness and cross-sectional area (CSA) compared to controls without neuropathy. This highlights the importance of ultrasound in detecting muscle atrophy early in diabetic patients since it provides objective measures beyond traditional screening with its real-time and non-invasive nature.

Loading

Article metrics loading...

/content/journals/cdr/10.2174/0115733998310010240711051523
2024-11-26
2025-11-02
Loading full text...

Full text loading...

References

  1. AtlasIDFD Available from: https://idf.org/aboutdiabetes/type-2-diabetes.html 2019
  2. ParasoglouP. RaoS. SladeJ.M. AuthorC.T. Declining skeletal muscle function in diabetic peripheral neuropathy.Clin. Ther.20173961085110310.1016/j.clinthera.2017.05.001 28571613
    [Google Scholar]
  3. Juster-switlykK. SmithA.G. Updates in diabetic peripheral neuropathy version 1.Peer review.2019517
    [Google Scholar]
  4. VinikA.I. BrilV. KemplerP. Treatment of symptomatic diabetic peripheral neuropathy with the protein kinase C β-inhibitor ruboxistaurin mesylate during a 1-year, randomized, placebo-controlled, double-blind clinical trial.Clin. Ther.20052781164118010.1016/j.clinthera.2005.08.001 16199243
    [Google Scholar]
  5. SiddiqueN. DurcanR. SmythS. TunT.K. SreenanS. McDermottJ.H. Acute diabetic neuropathy following improved glycaemic control: a case series and review.Endocrinol. Diabetes Metab. Case Rep.202010.1530/EDM‑19‑0140
    [Google Scholar]
  6. HuangH. WuS. Application of high-resolution ultrasound on diagnosing diabetic peripheral neuropathy.Diabetes Metab. Syndr. Obes.20211413915210.2147/DMSO.S292991 33469331
    [Google Scholar]
  7. StringerH.J. WilsonD. The Role of Ultrasound as a Diagnostic Tool for Sarcopenia.J. Frailty Aging201874258261 30298175
    [Google Scholar]
  8. TakaiY. OhtaM. AkagiR. Validity of ultrasound muscle thickness measurements for predicting leg skeletal muscle mass in healthy Japanese middle-aged and older individuals.J. Physiol. Anthropol.20133211210.1186/1880‑6805‑32‑12 24067065
    [Google Scholar]
  9. The campbell collaboration. campbell policies and guidelines series no. 1 campbell systematic reviews: policies and guidelines colophon title campbell systematic reviews: Policies and guidelines.20191145
    [Google Scholar]
  10. AllenM.D. DohertyT.J. RiceC.L. KimpinskiK. Physiology in Medicine: neuromuscular consequences of diabetic neuropathy.J. Appl. Physiol.201612111610.1152/japplphysiol.00733.2015 26989220
    [Google Scholar]
  11. SilvaE.Q. SudaE.Y. SantosD.P. Effect of an educational booklet for prevention and treatment of foot musculoskeletal dysfunctions in people with diabetic neuropathy: the FOotCAre (FOCA) trial II, a study protocol of a randomized controlled trial.Trials202021118010.1186/s13063‑020‑4115‑8 32054510
    [Google Scholar]
  12. OliverT.I. MutluogluM. Diabetic foot ulcer.In: StatPearls [Internet].Treasure Island (FL)StatPearls Publishing2024 30726013
    [Google Scholar]
  13. AMA. Evaluation and prevention of diabetic neuropathy.Am. Fam. Physician2005711121232130
    [Google Scholar]
  14. KumarC.G.S. RajagopalK.V. HandeH.M. MaiyaA.G. MayyaS.S. Intrinsic foot muscle and plantar tissue changes in type 2 diabetes mellitus.J. Diabetes20157685085710.1111/1753‑0407.12254 25496489
    [Google Scholar]
  15. F.ZIDAN HOWAYDA. Correlation between quantitative ultrasonography on small muscles of the foot in diabetic peripheral neuropathy and electrodiagnostic study.Med. J. Cairo Univ.202088121975198410.21608/mjcu.2020.125135
    [Google Scholar]
  16. KadhimZ.M. AlkhafajiM.M. The role of muscle thickness and echogenicity in the diagnosis of diabetic peripheral neuropathy.Neuroquantology202119811311810.14704/nq.2021.19.8.NQ21121
    [Google Scholar]
  17. WangX. ChenL. LiuW. SuB. ZhangY. Early detection of atrophy of foot muscles in Chinese patients of type 2 diabetes mellitus by high-frequency ultrasonography.J. Diabetes Res.20142014927069
    [Google Scholar]
  18. SeverinsenK. AndersenH. Evaluation of atrophy of foot muscles in diabetic neuropathy – A comparative study of nerve conduction studies and ultrasonography.Clin. Neurophysiol.2007118102172217510.1016/j.clinph.2007.06.019 17709290
    [Google Scholar]
  19. HendersonAD JohnsonAW RasmussenLG PeineWP SymonsSH ScoresbyKA Early-stage diabetic neuropathy reduces foot strength and intrinsic but not extrinsic foot muscle size.J Diabetes Res20202020
    [Google Scholar]
  20. ZurongY. YuandongL. XiankuiT. FuhaoM. TangL. JunkunZ. Morphological and mechanical properties of lower-limb muscles in type 2 diabetes: New potential imaging indicators for monitoring the progress of DPN.Diabetes202271122751276310.2337/db22‑0009 36125913
    [Google Scholar]
  21. Novaković BursaćS. JandrićS. TalićG. LjubojevićG. Complications of diabetes mellitus on muscles and joints of lower extremities.Scr. Med. (Brno)201849210511110.7251/SCMED1802105B
    [Google Scholar]
  22. KirwanJP SacksJ NieuwoudtS The essential role of exercise in the management of type 2 diabetes.Cleve Clin J Med2017847 suppl 1)(Suppl. 1S152110.3949/ccjm.84.s1.0328708479
    [Google Scholar]
  23. NomuraT. KawaeT. KataokaH. IkedaY. Assessment of lower extremity muscle mass, muscle strength, and exercise therapy in elderly patients with diabetes mellitus.Environ. Health Prev. Med.20182312010.1186/s12199‑018‑0710‑7 29776338
    [Google Scholar]
  24. GnaviR. SciannameoV. BarattaF. Opportunistic screening for type 2 diabetes in community pharmacies. Results from a region-wide experience in Italy.PLoS One2020153e022984210.1371/journal.pone.0229842 32187210
    [Google Scholar]
  25. RosenK.A. ThodgeA. TangA. FranzB.M. KlochkoC.L. SolimanS.B. The sonographic quantitative assessment of the deltoid muscle to detect type 2 diabetes mellitus: a potential noninvasive and sensitive screening method?BMC Endocr. Disord.202222119310.1186/s12902‑022‑01107‑2 35897066
    [Google Scholar]
/content/journals/cdr/10.2174/0115733998310010240711051523
Loading
/content/journals/cdr/10.2174/0115733998310010240711051523
Loading

Data & Media loading...

Supplements

PRISMA checklist is available as supplementary material on the publisher’s website along with the published article.

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test